155 related articles for article (PubMed ID: 34525796)
1. Engineered Attenuated
Hyun J; Jun S; Lim H; Cho H; You SH; Ha SJ; Min JJ; Bang D
ACS Synth Biol; 2021 Oct; 10(10):2478-2487. PubMed ID: 34525796
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Targeting Salmonella typhimurium A1-R Promotes Tumoricidal CD8
Murakami T; Hiroshima Y; Zhang Y; Zhao M; Kiyuna T; Hwang HK; Miyake K; Homma Y; Mori R; Matsuyama R; Chishima T; Ichikawa Y; Tanaka K; Bouvet M; Endo I; Hoffman RM
J Cell Biochem; 2018 Jan; 119(1):634-639. PubMed ID: 28628234
[TBL] [Abstract][Full Text] [Related]
3. Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth.
Loeffler M; Le'Negrate G; Krajewska M; Reed JC
Cancer Immunol Immunother; 2009 May; 58(5):769-75. PubMed ID: 18633610
[TBL] [Abstract][Full Text] [Related]
4. Targeted cancer immunotherapy with genetically engineered oncolytic Salmonella typhimurium.
Guo Y; Chen Y; Liu X; Min JJ; Tan W; Zheng JH
Cancer Lett; 2020 Jan; 469():102-110. PubMed ID: 31666180
[TBL] [Abstract][Full Text] [Related]
5. SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria.
Nagarajan AG; Balasundaram SV; Janice J; Karnam G; Eswarappa SM; Chakravortty D
Vaccine; 2009 May; 27(21):2804-11. PubMed ID: 19428891
[TBL] [Abstract][Full Text] [Related]
6. Modulation of host immune responses stimulated by Salmonella vaccine carrier strains by using different promoters to drive the expression of the recombinant antigen.
Medina E; Paglia P; Rohde M; Colombo MP; Guzmán CA
Eur J Immunol; 2000 Mar; 30(3):768-77. PubMed ID: 10741391
[TBL] [Abstract][Full Text] [Related]
7. Combinational immunotherapy for established tumors with engineered tumor vaccines and adenovirus-mediated gene transfer.
Xiang J; Chen Y; Moyana T
Cancer Gene Ther; 2000 Jul; 7(7):1023-33. PubMed ID: 10917205
[TBL] [Abstract][Full Text] [Related]
8. In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines.
Nishikawa H; Sato E; Briones G; Chen LM; Matsuo M; Nagata Y; Ritter G; Jäger E; Nomura H; Kondo S; Tawara I; Kato T; Shiku H; Old LJ; Galán JE; Gnjatic S
J Clin Invest; 2006 Jul; 116(7):1946-54. PubMed ID: 16794737
[TBL] [Abstract][Full Text] [Related]
9. Salmonella enterica serovar Typhimurium strain lacking pmrG-HM-D provides excellent protection against salmonellosis in murine typhoid model.
Negi VD; Singhamahapatra S; Chakravortty D
Vaccine; 2007 Jul; 25(29):5315-23. PubMed ID: 17574312
[TBL] [Abstract][Full Text] [Related]
10. High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4
Hernandez R; LaPorte KM; Hsiung S; Santos Savio A; Malek TR
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34475132
[TBL] [Abstract][Full Text] [Related]
11. Chicken egg yolk antibodies (IgY) modulate the intestinal mucosal immune response in a mouse model of Salmonella typhimurium infection.
Li X; Yao Y; Wang X; Zhen Y; Thacker PA; Wang L; Shi M; Zhao J; Zong Y; Wang N; Xu Y
Int Immunopharmacol; 2016 Jul; 36():305-314. PubMed ID: 27214338
[TBL] [Abstract][Full Text] [Related]
12. CD27 Agonism Plus PD-1 Blockade Recapitulates CD4+ T-cell Help in Therapeutic Anticancer Vaccination.
Ahrends T; Bąbała N; Xiao Y; Yagita H; van Eenennaam H; Borst J
Cancer Res; 2016 May; 76(10):2921-31. PubMed ID: 27020860
[TBL] [Abstract][Full Text] [Related]
13. Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains.
Chen H; Schifferli DM
Infect Immun; 2000 Jun; 68(6):3129-39. PubMed ID: 10816454
[TBL] [Abstract][Full Text] [Related]
14. Use of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in mice.
Gentschev I; Fensterle J; Schmidt A; Potapenko T; Troppmair J; Goebel W; Rapp UR
BMC Cancer; 2005 Feb; 5():15. PubMed ID: 15703070
[TBL] [Abstract][Full Text] [Related]
15. Gamma/delta T cell response of chickens after oral administration of attenuated and non-attenuated Salmonella typhimurium strains.
Berndt A; Methner U
Vet Immunol Immunopathol; 2001 Jan; 78(2):143-61. PubMed ID: 11182154
[TBL] [Abstract][Full Text] [Related]
16. A liposomal RNA vaccine inducing neoantigen-specific CD4
Salomon N; Vascotto F; Selmi A; Vormehr M; Quinkhardt J; Bukur T; Schrörs B; Löewer M; Diken M; Türeci Ö; Sahin U; Kreiter S
Oncoimmunology; 2020 Jun; 9(1):1771925. PubMed ID: 32923128
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects in mice of the intravenous injection of attenuated Salmonella typhimurium.
Rosenberg SA; Spiess PJ; Kleiner DE
J Immunother; 2002; 25(3):218-25. PubMed ID: 12000863
[TBL] [Abstract][Full Text] [Related]
18. In vivo compartmentalization of functionally distinct, rapidly responsive antigen-specific T-cell populations in DNA-immunized or Salmonella enterica serovar Typhimurium-infected mice.
Kirby AC; Sundquist M; Wick MJ
Infect Immun; 2004 Nov; 72(11):6390-400. PubMed ID: 15501769
[TBL] [Abstract][Full Text] [Related]
19. Antibody is required for protection against virulent but not attenuated Salmonella enterica serovar typhimurium.
McSorley SJ; Jenkins MK
Infect Immun; 2000 Jun; 68(6):3344-8. PubMed ID: 10816483
[TBL] [Abstract][Full Text] [Related]
20. Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine.
Chang EY; Chen CH; Ji H; Wang TL; Hung K; Lee BP; Huang AY; Kurman RJ; Pardoll DM; Wu T
Int J Cancer; 2000 Jun; 86(5):725-30. PubMed ID: 10797297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
